Proprioception Testing in Persons With Sensorimotor Impairment

N/ATerminatedNCT01974635

Oregon Health and Science University2 enrolled

Overview

In this study, an FDA-cleared device and type of treatment called "AMES," which stands for Assisted Movement with Enhanced Sensation, will be used to determine whether sensation in the upper limb of individuals with incomplete spinal cord injuries, acquired brain injury, or stroke improves along with movement through treatment. We hypothesize that measureable improvement in the sensation of the upper limb will precede improvement in functional movement.

The AMES device performs tests of sensorimotor impairment as well as delivering therapy. In this study, we are testing 2 additional diagnostic tests (i.e., Joint Position Test and "Frisbee" Test), both of proprioception, in order to determine which of the two is the best test of proprioception. Our hypotheses are: (1) both sensation and movement recover with AMES treatment, (2) sensory recovery precedes that of movement, (3) robotic delivery of the Joint Position Test produces more reliable test results than does manual delivery of this test, and (4) the Frisbee Test results will parallel those of the Joint Position Test.

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Spinal Cord Injury Stroke Acquired Brain Injury

Interventions

AMES TherapyDEVICE

During the therapy session, the AMES device rotates the hand into flexion and extension, while the patient assists with this motion, as possible. At the same time, the AMES device provides sensory stimulation by vibrating the tendons of muscles stretched by the movement. The vibratory stimulus switches from one side of the limb to the other when the rotation reverses direction so that the sensory stimulation remains functionally related to the movement. The subject will receive visual bio-feedback of their contribution to the motor movement.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Traumatic incomplete SCI, stroke or acquired brain injured ABI subjects. * Able to tolerate sitting upright at for at least 1 hour. * Significant, but not complete, motor deficit in the hand and wrist, as determined by the Study Physician performing the screening. * Significant, but not complete somatosensory deficit in the hand and wrist as determined by the Study Physician performing the screening. * Cognitively and behaviorally capable of complying with the regimen. Exclusion Criteria: * Fracture of the treated limb resulting in loss of range of motion. * Progressive neurodegenerative disorder. * DVT of the treated extremity. * Uncontrolled seizure disorder. * Uncontrolled high blood pressure/angina. * Osteo- or rheumatoid arthritis limiting range of motion * Contractures equal to or greater than 50% of the normal ROM. * Chronic ITB therapy. * Peripheral nerve injury of the treated extremity. * Pain in affected limb or exercise intolerance. * Participation in another therapy or activity-based program. * Skin condition not tolerant of device.

Locations (1)

Oregon Health and Science University

Portland, Oregon, United States

Outcomes

Primary Outcomes

Joint Position Test - AMES Device

Testing proprioceptive sensation, the subject, with eyes closed, attempts to identify verbally the direction of motion (i.e., flexion or extension) as the AMES device randomly moves the subject's thumb and fingers, or the whole hand, into flexion and extension.

Time frame: Immediately after each treatment on the AMES Device

Secondary Outcomes

Frisbee Test - Device

Testing proprioceptive sensation, the AMES device moves the subject's wrist through a 30 degree range, at variable speeds, as the subject attempts to identify when their wrist reaches a particular target, either by opening contact between the thumb and index finger (if possible) or blinking the eyes. The subject receives feedback about the accuracy of the testing.

Time frame: After each treatment on the AMES device.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.